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Abstract
Background: Lethal pancreatitis has been reported after treatment for common bile duct stones using small
endoscopic papillary balloon dilation.
Methods: We retrospectively evaluated the safety and efficacy of using large balloon dilation alone without the
use of sphincterotomy for the treatment of large common bile duct stones in Kaohsiung Veterans General Hospital.
Success rate of stone clearance, procedure-related adverse events and incidents, frequency of mechanical
lithotripsy use, and recurrent stones were recorded.
Results: A total of 247 patients were reviewed in the current study. The mean age of the patients was 71.2 years.
Most of them had comorbidities. Mean stone size was 16.4 mm. Among the patients, 132 (53.4%) had an intact
gallbladder and 121 (49%) had a juxtapapillary diverticulum. The mean size of dilating balloon used was 13.2 mm.
The mean duration of the dilating procedure was 4.7 min. There were 39 (15.8%) patients required the help of
mechanical lithotripsy while retrieving the stones. The final success rate of complete retrieval of stones was 92.7%.
The rate of pancreatic duct enhancement was 26.7% (66/247). There were 3 (1.2%) adverse events and 6 (2.4%)
intra-procedure bleeding incidents. All patients recovered completely after conservative and endoscopic treatment
respectively, and no procedure-related mortality was noted. 172 patients had a follow-up duration of more than 6
months and among these, 25 patients had recurrent common bile duct stones. It was significantly correlated to
the common bile duct size (p = 0.036)
Conclusions: Endoscopic papillary large balloon dilation alone is simple, safe, and effective in dealing with large
common bile duct stones in relatively aged and debilitated patients.
Background
Endoscopic sphincterotomy (EST) is effective in the
treatment of common bile duct stones (CBDS), with
complete stone removal in 85%-90% of patients [1-3].
However, EST is technically demanding and the likeli-
hood of complications is closely related to the skill and
training of the endoscopist [4].
Endoscopic papillary balloon dilation (EPBD), which is
easy to perform using the wire-guided method, has
become an alternative to EST for the treatment of
CBDS since its first introduction by Staritz in 1982 [5].
EPBD (balloon length, 3 cm; maximum inflated outer
diameter, 8 mm; and duration of inflation, 45-60 s) pos-
sesses the advantages of less bleeding, preservation of
biliary sphincter function, and a reduced risk of acute
cholecystitis during the follow-up period. However, for
patients with difficult stones (diameter > 10 mm or
number of stones > 3), mechanical lithotripsy is more
frequently used after EPBD (between 10% and 50% of
case), and additional sphincterotomy or repeat ERCP
may also be needed [6-8]. Moreover, increased morbid-
ity and lethal pancreatitis have been reported [9] after
* Correspondence: khlai@vghks.gov.tw
1Division of Gastroenterology, Department of Internal Medicine, Kaohsiung
Veterans General Hospital, 386 Ta-Chung 1st Road, Kaohsiung 81362, Taiwan
Full list of author information is available at the end of the article
Chan et al. BMC Gastroenterology 2011, 11:69
http://www.biomedcentral.com/1471-230X/11/69
© 2011 Chan et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.EPBD using a standard balloon catheter (8 mm). The
authors of that study claimed that the post-EPBD pan-
creatitis was probably due to edematous change or
trauma after the dilation procedure, resulting in the
obstruction of the pancreatic duct.
Recent studies [10,11] have shown that EST followed
by large balloon dilation or large balloon dilation only
[12] for the removal of large or difficult stones from the
CBD have good efficacy and acceptable complication
rates. However, the optimal extent of EST is not known
and the procedure is technically demanding when two
types of sphincteroplasty are used instead of one. Theo-
retically, endoscopic papillary large balloon dilation
(EPLBD) without EST is easier to manipulate than the
combinatorial method and is also more suitable for
patients with concomitant large stones and bleeding ten-
dency. In order to evaluate the efficacy and safety of
EPLBD alone in the treatment of CBDS, we conducted a
retrospective study to investigate the effect of this
method in patients with large CBDS in our center.
Methods
Between September 2001 and September 2009, consecu-
tive patients with large CBDS (> 10 mm) managed by
EPLBD alone (size of dilating balloon > 10 mm, without
EST) were reviewed in Kaohsiung Veterans General
Hospital, Taiwan.
Local anesthesia of the pharynx was obtained using
10% xylocaine, and intramuscular injection with 40 mg
hyoscine-N-butylbromide and 25-50 mg meperidine
were administered as premedication. ERCP was per-
formed in the standard manner using a side-view endo-
scope (JF-240; Olympus Optical Corporation, Tokyo,
Japan). After selective cannulation of the common bile
duct by the catheter, cholangiography was performed to
confirm the diagnosis of CBDS. A 0.035-inch guidewire
(Boston Scientific, Corp, MA, USA) was then inserted
into the bile duct through the catheter. A dilating bal-
loon (CRE balloon 5.5 cm in length, 1-1.2 cm/1.2-1.5
cm/1.5-2.0 cm in diameter; Boston Scientific, Corp, Ire-
land) was passed via the pre-positioned guidewire into
t h eb i l ed u c t .U s i n gf l u o r o s c o p i ca n de n d o s c o p i cg u i -
dance, the balloon was inflated with sterile saline solu-
tion up to the optimal size (at least > 10 mm in
diameter) and duration (usually 2-6 min) according to
the patients’ condition and tolerance. In order to mini-
mize the risk of perforation, the size of the balloon
should be not exceeded the size of the CBD. After
removal of the balloon and guidewire, the CBDS were
removed using a Dormia basket or balloon-tipped cathe-
ter with or without the aid of mechanical lithotripsy. A
mechanical lithotripter (BML-4Q; Olympus Optical,
Tokyo, Japan) was used to fragment the stones if they
were larger than the diameter of the distal bile duct or
were difficult to remove using the Dormia basket or bal-
loon-tipped catheter. A second attempt at stone extrac-
tion was performed within 7 days if there was
incomplete removal of stones in the first treatment ses-
sion. All of the patients were observed in the hospital
for at least 24 h after endoscopic treatment. Procedure-
related adverse events and incidents were recorded
according to the definitions and grading systems of the
recent workshop held by the American Society of Gas-
trointestinal Endoscopy [13]. During the ERCP proce-
dure, juxtapapillary diverticulum, CBD and stone sizes,
stone numbers, and positive pancreatic duct enhance-
ment were recorded. Stone removal was declared as
complete if the final cholangiogram showed no residual
stones. Clinical evaluation for symptoms and serum
amylase was performed on the following day. Patients
with complete clearance of the bile duct were assigned
to regular follow-up after discharge. During each visit, a
blood sample was routinely taken for liver function
tests. Abdominal ultrasound was suggested every 6-12
months or at the time of abnormal liver function test or
clinical symptoms suggesting the recurrence of stones.
ERCP was performed if recurrent biliary symptoms,
abnormal liver function, or sonographic analysis sug-
gested recurrent CBDS. When repeat ERCP confirmed
the diagnosis of recurrent CBDS, endoscopic removal of
stones (with or without further balloon dilation) was
performed simultaneously in the same session, or the
patient was referred to the surgical department. Tele-
phone contact was made with patients who were unable
to return to the hospital.
The current study was approved by the Institutional
Review Board of Kaohsiung Veterans General Hospital.
The values are expressed as the mean ± SD. Categorical
variables were analyzed using a c
2-test or Fisher’s exact
test and continuous variables were analyzed using Stu-
dent’s t-test. A P value < 0.05 was regarded as significant.
Results
A total of 247 patients were reviewed in the current
study. The patients’ characteristics are shown in Table 1.
The mean age of the patients was 71.2 (76% ≧ 65 years).
The mean CBD size was 18.1 mm. The mean number of
stones was 2.3, and the mean stone size was 16.4 mm. Of
the 247 patients assessed, 132 (53.4%) had an intact gall-
bladder (86 had gallbladder stones) and 121 (49%) had a
juxtapapillary diverticulum. Presenting symptoms
included abdominal pain, 179 (72.5%); fever, 92 (37.3%);
jaundice, 155 (62.8%); and pancreatitis, 18 (7.3%). The
comorbidities of patients graded by the American Society
for Anesthesia Classification are shown in Table 2.
Concerning the process of the EPLBD, the mean size
of dilating balloon used was 13.2 mm. The duration of
the dilating procedure ranged from 2 to 6 min. For 39
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Page 2 of 6(15.8%) patients, mechanical lithotripsy was needed
while retrieving the stones. The success rate of complete
retrieval of the CBDS within the first session of treat-
ment was 81.8% (202/247). In a further 27 patients,
stones were successfully extracted in the second session
of treatment (final success rate: 92.7%). Among those
patients, for whom complete stone extraction was not
successful (18/247), the failure was due to either stone
impaction (13) or intolerance of patients (5), with seven
needed placement of a plastic stent and eleven were
sent for surgical treatment. The rate of pancreatic duct
enhancement was 26.7% (66/247). There were 3 (1.2%)
adverse events, which include 2 (0.8%) cases of mild
pancreatitis and 1 (0.4%) mild cholangitis. In addition,
there were six (2.4%) intra-procedure bleeding incidents.
All patients recovered completely after conservative and
endoscopic treatment respectively, and no procedure-
related mortality was noted. A total of 172 patients had
a follow-up duration of 6 months or more (mean: 30.2
± 20.2 months), of whom, 25 patients had recurrent
CBDS. The mean duration of recurrence of CBDS was
27.1 ± 17.9 months (Table 3). Table 4 showed that the
recurrence of stones was not related to the age, sex, size
and number of stones, use of mechanical lithotripsy and
presence of juxtapapillary diverticulum (p >0 . 0 5 ) .
Instead, it was significantly correlated to the CBD size
(p = 0.036). For those who had recurrent stones,
repeated ERCP with stone extraction was performed
successfully in 10 patients and repeated balloon dilation
was needed for accessing the stone in another 14
patients. One of the patients was sent for surgery.
Among these patients, 19 presented with acute cholangi-
tis. Moreover, 9 patients received cholecystectomy due
to acute cholecystitis during the follow-up period.
Discussion
Since the introduction of EPBD in 1982, there has been
continuous debate regarding the safety of this procedure
for the treatment of CBDS. Differences in the outcomes
o ft h e s ep r o c e d u r e sm a yb ep a r t l yd u et od i f f e r e n c e s
among the trials regarding both the inclusion criteria
and the methods of preparing for and performing the
procedures [6,14-20].
Apart from the aforementioned traditional EPBD
method (maximum inflated outer diameter of 8 mm),
large controlled radial expansion (CRE) balloon dilation
(10-20 mm diameter dilating balloon), which was initi-
ally applied for dilation of the esophagus or gastric
pylorus, acts as a rescue therapy after the failure of
stone extraction using conventional EST plus standard
basket/balloon-tipped device sd u et ol a r g es t o n es i z eo r
tapering of the distal bile duct. It has a high success rate
of stone clearance, fewer complications (including pan-
creatitis), and minimizes the use of mechanical litho-
tripsy [21,22]. A subsequent randomized controlled trial
[23] also demonstrated that EST plus EPLBD is a safe
and effective alternative to EST alone in the treatment
of CBDS. However, because sphincterotomy is arbitrary
during combination therapy and the procedure is tech-
nically demanding when compared with EST or balloon
dilation alone, there has been no significant decrease in
lithotripsy use, even though the complication rate asso-
ciated with the combined therapy is low [10].
T h ec u r r e n ts t u d yi n v o l v e d2 4 7r e l a t i v e l ya g e dp e o p l e
(mean age: 71 years) who were suffering from consider-
able amounts of comorbidities. Unfortunately, most of
Table 1 Patients’ characteristics
Characteristics %
Sex (M/F) 157/90 63.6/36.4
Age (mean ± SD, years) 71.2 ± 13.5 (18-98)
Mean size of CBD (mm) 18.1 ± 5.0 (8-40)
Mean size of CBD stones (mm) 16.4 ± 5.2 (11-39)
Mean number of stones 2.3 ± 1.5 (1-11)
(Single/Multiple) 88/159 35.6/64.4
Intact gallbladder 132/247 53.4
(Gallbladder stones) 86
Juxtapapillary diverticulum 121/247 49
Symptoms
Pain 179/247 72.5
Fever 92/247 37.3
Jaundice 155/247 62.8
Pancreatitis 18/247 7.3
WBC (× 10
3 cu mm
-1) 11.0 ± 5.7
Platelet (× 10
3 cu mm
-1) 205 ± 83
AST (IU/L) 154 ± 189
ALT (IU/L) 160 ± 169
Alk-P (IU/L) 298 ± 232
r-GT (IU/L) 511 ± 445
Total bilirubin (mg/dL) 3.6 ± 3.3
INR (international normalized ratio) 1.06 ± 0.16
Table 2 Comorbidities of patients were graded by the American Society for Anesthesia (ASA) Classification
ASA Classification Medical description of patients No. of patients (%)
I No known systemic disease 115 (46.6)
II Mild or well controlled systemic disease (s) 43 (17.4)
III Multiple or moderately controlled systemic disease (s) 63 (25.5)
IV Poorly controlled systemic disease (s) 26 (10.5)
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Page 3 of 6these patients had also suffered from symptomatic large
CBDS for which surgical treatment was not the first
choice due to their underlying problems. These asso-
ciated diseases increase the difficulty of performing
ERCP procedures for patients who are also vulnerable to
developing complications during conscious sedation or
general anesthesia. A previous pilot study about the
effect of large balloon dilation [12] reported a ballooning
time (duration of dilating procedure) of 10-60 seconds,
which is quite different from the 2-6 minutes in this
study. However, both resulted in a low rate of pancreati-
tis. This further emphasizes the safety of the procedure,
which is independent of the ballooning time. In addi-
tion, a recent study also demonstrated that 5-minute
ballooning time improved efficacy of stone extraction
and reduced the risk of pancreatitis [24].
In order to shorten the procedure time as well as
minimizing the chance of complications, simplifying the
procedure while maintaining the effectiveness of stone
removal is warranted. Therefore, in the past few years,
when we have encountered large CBD stones, we have
adopted EPLBD only in our treatment scheme instead
of using it in combination with EST.
We found that the success rate of bile duct clearance
after EPLBD was high although repeat sessions may be
needed to secure the result. Moreover, the adverse
events and incidents of EPLBD are acceptable. The
possible causes of the low rate of pancreatitis include,
the relatively old age of the patients in the current
study (mean age: 71 years), [25,26] which may be due
to the progressive decline in pancreatic exocrine func-
tion associated with aging that could protect older
patients from pancreatic injury. In addition, we try to
selectively cannulate the CBD when performing the
ERCP, and avoid cannulating or excessive injection of
the pancreatic duct [27]. However, according to our
experience, we sometimes had difficulty in selectively
cannulate the CBD, which resulted in injecting the
pancreatic duct with contrast medium accidentally.
During this situation, once the head portion of pan-
creatic duct was filled with contrast, we would stop
inject the contrast medium immediately and withdraw
the catheter in order to minimize the unwanted
adverse events. Moreover, large balloon dilation results
in a large opening of the bile duct, which can prevent
accidental cannulation of the pancreatic duct in the
subsequent stone extraction and stone impaction in
the common channel. Consequently, there is little need
to apply mechanical lithotripsy in these cases.
Although 25 patients had recurrent CBDS, they were
easily handled by endoscopic treatment. Regular fol-
low-up may be necessary, particularly for high risk
patients such as those with large bile duct or poor
biliary emptying [28,29].
With regard to the limitations of our current study, it
suffers from the usual shortcomings associated with ret-
rospective research, which include: a) what kind of
patients should be treated by large balloon dilation, b)
lack of well-defined optimal size of balloon dilation and
the related ballooning time, c) complications may be
underestimated, d) no standard follow-up was applied,
e) relative high stone recurrence rate although a final
cholangiogram was obtained to confirm the bile duct
clearance for every patient, and f) significant number of
patients were lost to follow-up. Further large rando-
mized prospective studies may be needed to substantiate
the true efficacy of EPLBD.
Conclusions
Endoscopic papillary large balloon dilation alone is sim-
ple, safe, and effective in dealing with large CBDS in
relatively aged and debilitated patients.
Table 4 Clinical parameters vs. patients with recurrent
CBD stones
Clinical
parameters
Recurrence (n =
25)
No recurrence (n =
222)
P
value
Age (year) 70.0 (11.75) 71.3 (13.75)* 0.649
Sex (male:female) 14:11 143:79 0.511
Stone number 1.76 (0.93) 2.39 (1.58) 0.051
Stone size 1.63 (0.49) 1.65 (0.52) 0.896
CBD size 2.01 (0.61) 1.79 (0.49) 0.036
⋇
Lithotripsy (+/-) 2/23 37/185 0.387
JPD (+/-) 13/12 108/114 0.834
CBD, Common bile duct.
JPD, Juxtapapillary diverticulum.
*Values expressed as the mean ± standard deviation.
⋇Statistically significant.
Table 3 Results of EPLBD in the treatment of large
common bile duct stones
Mean size of dilating balloon (mm) 13.2 ± 2.2 (11-20)
Mean duration of dilating procedure (min) 4.7 ± 0.7 (2-6)
Pancreatic duct visualization 66 (26.7%)
Number (rate) of mechanical lithotripsy 39/247 (15.8%)
Treatment success (first session) 202/247 (81.8%)
(second session) 27
(total) 229 (92.7%)
Adverse events 3/247 (1.2%)
Pancreatitis (mild) 2/247 (0.8%)
Cholangitis (mild) 1/247 (0.4%)
Incidents: Intra-procedure bleeding 6/247 (2.4%)
Procedure-related mortality 0
Follow-up duration ≧ 6 months 172/247
Mean duration of follow-up (months) 30.2 ± 20.2
Number of recurrent CBDS 25
Mean duration to recurrence (months) 27.1 ± 17.9
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